Guangzhou has opened a state-backed centre to organise its pitch to foreign patients, China Daily reported. The city is the capital of Guangdong province. It has launched the Guangzhou International Medical Tourism Service Center to build what officials called a globally competitive destination for international medical tourism. The centre will work with seventeen pilot hospitals across Guangzhou. It will offer diagnosis and treatment for foreign patients, and will also run brand marketing, medical agency work, travel arrangements and wellness provision, China Daily reported.
The programme is pitched at the wider region. It draws on the cultural, commercial and tourism assets of the Guangdong-Hong Kong-Macao Greater Bay Area, and folds medical care, tourism and city services into one offer. Lai Zhihong, vice-mayor of Guangzhou, said international medical tourism had become an important growth driver in the global health industry. Demand for treatment in the city had kept growing, Lai said, supported by its medical resources, its Lingnan culture, its open setting and its status as a transport hub. Lai urged medical staff to hold to high standards of service, expertise and ethics.
The demand claim rests on a single headline figure. Official data showed that inbound visits by foreigners to Guangzhou passed 3.2 million in 2025, China Daily reported, with foreign residents’ demand for medical services rising fast. That 3.2 million is a general inbound-travel count, not a tally of medical patients. The gap between the two is exactly the gap the new centre has been built to close.
Twelve measures target talent and TCM
Chen Bin, director of the Guangzhou Municipal Health Commission, announced twelve measures to support international medical services. Chen said the measures would focus on “building an international medical service brand”, alongside industrial layout, an international medical centre and stronger specialist disciplines. The measures make it easier for foreign doctors and nurses, and for practitioners from Hong Kong, Macao and Taiwan, to hold multisite practice in Guangzhou. Pilot institutions may also create special posts to recruit senior international medical talent.
Traditional Chinese medicine sits at the centre of the pitch. Hospitals are urged to promote TCM and to set up high-level acupuncture centres for foreign patients, Chen said. That is a deliberate choice, and a sound one. Patients cross a border for five reasons: better care, the best care, cheaper care, faster care, or care unavailable at home. Acupuncture and TCM belong to the last, the treatment a patient cannot get in the same form at home. Guangzhou is not competing with Delhi or Bangkok on the price of a hip replacement here. It is selling a speciality that is genuinely local, and the acupuncture and TCM centres are the part of the programme least exposed to price competition from other Asian corridors. The corridors that move orthopaedic and oncology patients compete on price and speed, and telemedicine can carry much of their consultation; a TCM speciality competes on something a rival corridor cannot copy or stream.
Hospitals say they are ready. A vice-president at one of the participating university hospitals said the measures gave a firm guarantee for efficient international care, and that hospitals would keep improving their diagnosis environments, their multilingual systems and their multidisciplinary capabilities across specialities for patients from Hong Kong, Macao, Southeast Asia and Belt and Road Initiative countries. The spread of target markets is worth marking. Guangzhou is aiming at the Greater Bay Area, Southeast Asia and the Belt and Road countries at once, a deliberately broad basket rather than one dominant source market.
The machinery matters more than the brand
Wu Chen, general manager of the centre, said it brought together the city’s medical resources, its cultural tourism assets and cross-border commercial insurance, and would work with major hospitals to give overseas patients one-stop services. Those services, China Daily reported, run from visa help and remote pre-consultation through multilingual translation and travel to postoperative follow-up.
That list is the real test, and it tells more than the brand campaign beside it. A medical tourism destination is not made by marketing. It is made by the dull machinery a patient touches: the visa letter that arrives on time, the interpreter in the consultation room, the insurance claim that clears across a border, the postoperative follow-up that reaches a patient after they fly home. Guangzhou has named all four in its own service list, which is the encouraging part. The centre is, in effect, a state-run facilitator, and that shifts the usual complaint about facilitators, who tend to sell visibility rather than trust. A government body carries an accountability that a private middleman does not. Marketing does not clear an insurance claim, and telemedicine does not carry a patient to a theatre; the facilitator that solves the dull logistics is the facilitator that keeps the patient. Whether that accountability turns into cleared insurance claims and staffed multilingual desks across seventeen hospitals is the question the coming year will answer.
The programme also blurs the line the sector usually draws. Diagnosis and treatment sit at the clinical end. The TCM, wellness and healthcare services sit nearer the wellness end, and Guangzhou is selling both from one desk. That hybrid is common now, but it carries a coordination cost, because the accredited clinical work and the wellness work are judged on different things, safety and outcomes on one side, experience on the other, and one centre now has to hold both standards at once. A postoperative check and a TCM wellness stay are booked from the same desk yet measured on different scales.
What operators should watch
The measurable tests are close. The first is whether the twelve measures arrive with budgets and dates rather than as a framework, because a framework without funding does not staff a multilingual desk. The second is whether named international insurers sign up to the cross-border settlement the centre has promised, since that is what turns a foreign enquiry into a booked procedure. The third is the count of foreign and Hong Kong, Macao and Taiwan clinicians who actually take up multisite practice in Guangzhou, the clearest early sign that the talent measures are more than an announcement rather than a working facilitator. If those three move, the 3.2 million inbound visits could begin to convert into medical arrivals. If they stall, Guangzhou will have a brand and not yet a destination.
